Literature DB >> 9457747

Alport syndrome. A review of the ocular manifestations.

D J Colville1, J Savige.   

Abstract

Alport syndrome has a prevalence of 1/5000, and 85% of patients have the X-linked form, where affected males develop renal failure and usually have a high-tone sensorineural deafness by the age of 20. The typical ocular associations are a dot-and-fleck retinopathy which occurs in about 85% of affected adult males, anterior lenticonus which occurs in about 25%, and the rare posterior polymorphous corneal dystrophy. The retinopathy and anterior lenticonus are not usually demonstrated in childhood but worsen with time so that the retinal lesion is often present at the onset of renal failure, and the anterior lenticonus, later. The demonstration of a dot-and-fleck retinopathy in any individual with a family history of Alport syndrome or with end-stage renal disease is diagnostic of Alport syndrome. The presence of anterior lenticonus or posterior polymorphous corneal dystrophy in any individual is highly suggestive of the diagnosis of Alport syndrome. Additional ocular features described in X-linked Alport syndrome include other corneal dystrophies, microcornea, arcus, iris atrophy, cataracts, spontaneous lens rupture, spherophakia, posterior lenticonus, a poor macular reflex, fluorescein angiogram hyperfluorescence, electrooculogram and electroretinogram abnormalities, and retinal pigmentation. All mutations demonstrated to date in X-linked Alport syndrome have affected the COL4A5 gene which encodes the alpha 5 chain of type IV collagen. This protein is probably common to the basement membranes of the glomerulus, cochlea, retina, lens capsule, and cornea. However, the alpha 3(IV) and 4(IV) as well as the alpha 5(IV) collagen chains are usually absent from the affected basement membranes, because the abnormal alpha 5(IV) molecule interferes with the stability of all three. The loss of these collagen molecules from the affected basement membranes results in an abnormal ultrastructural appearance. The ocular and other clinical features of autosomal recessive Alport syndrome are identical to those seen in X-linked disease, while retinopathy and cataracts are the only ocular abnormalities described in the rare autosomal dominant form of Alport syndrome. There are no ocular associations of thin basement membrane disease which is a common disease that probably represents the heterozygous expression of X-linked or autosomal recessive Alport syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9457747     DOI: 10.3109/13816819709041431

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  49 in total

1.  A locus for posterior polymorphous corneal dystrophy (PPCD3) maps to chromosome 10.

Authors:  Satoko Shimizu; Charles Krafchak; Nobuo Fuse; Michael P Epstein; Miriam T Schteingart; Alan Sugar; Maya Eibschitz-Tsimhoni; Catherine A Downs; Frank Rozsa; Edward H Trager; David M Reed; Michael Boehnke; Sayoko E Moroi; Julia E Richards
Journal:  Am J Med Genet A       Date:  2004-11-01       Impact factor: 2.802

2.  Genotype-phenotype correlation in X-linked Alport syndrome.

Authors:  Mir Reza Bekheirnia; Berenice Reed; Martin C Gregory; Kim McFann; Alireza Abdollah Shamshirsaz; Amirali Masoumi; Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 10.121

3.  Ocular manifestations of Alport syndrome.

Authors:  Jian-Min Xu; Shi-Sheng Zhang; Qiong Zhang; Ying-Ming Zhou; Cai-Hong Zhu; Jian Ge; Ling Wang
Journal:  Int J Ophthalmol       Date:  2010-06-18       Impact factor: 1.779

Review 4.  Ocular features in Alport syndrome: pathogenesis and clinical significance.

Authors:  Judy Savige; Shivanand Sheth; Anita Leys; Anjali Nicholson; Heather G Mack; Deb Colville
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-03       Impact factor: 8.237

5.  [Unclear deterioration of vision after renal transplant].

Authors:  M Hild; H-S Walter; G Milioti; B Seitz
Journal:  Ophthalmologe       Date:  2009-11       Impact factor: 1.059

6.  Zeb1 mutant mice as a model of posterior corneal dystrophy.

Authors:  Yongqing Liu; Xiaoyan Peng; Jinlian Tan; Douglas S Darling; Henry J Kaplan; Douglas C Dean
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05       Impact factor: 4.799

7.  Morning glory syndrome associated with posterior lenticonus.

Authors:  Xiao-Guang Cao; Xiao-Xin Li; Yong-Zhen Bao
Journal:  Open Neurol J       Date:  2009-06-30

Review 8.  Lens capsule as a model to study type IV collagen.

Authors:  Christopher F Cummings; Billy G Hudson
Journal:  Connect Tissue Res       Date:  2014 Jan-Feb       Impact factor: 3.417

9.  Biochemical and biophysical changes underlie the mechanisms of basement membrane disruptions in a mouse model of dystroglycanopathy.

Authors:  Peng Zhang; Yuan Yang; Joseph Candiello; Trista L Thorn; Noel Gray; Willi M Halfter; Huaiyu Hu
Journal:  Matrix Biol       Date:  2013-02-27       Impact factor: 11.583

10.  Progressive posterior lenticonus in a patient with alport syndrome.

Authors:  Ammar M Al-Mahmood; Samar A Al-Swailem; Abdulrahman Al-Khalaf; Ghada Y Al-Binali
Journal:  Middle East Afr J Ophthalmol       Date:  2010-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.